# Health Catalyst

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/health-catalyst

- Industry: Healthcare IT
- Headquarters: Salt Lake City, US
- Website: www.healthcatalyst.com
- Total disclosed funding: $260M
- Latest round: Series F (Feb 6, 2019)
- Investors on record: 15

## About

Health Catalyst, Inc. is a US-based company that specializes in providing advanced data and analytics technology tailored for healthcare organizations, enhancing their decision-making and operational efficiency.Founded in 2008 in Salt Lake City, US, Health Catalyst, Inc. delivers data analytics solutions for healthcare entities. The company was co-founded by Steven Barlow and Tom Burton, and is led by CEO Dan Burton. Health Catalyst has successfully raised USD 182.00 mn through an IPO on July 24, 2019, and has a total fundraising amount of USD 182.00 mn.Health Catalyst specializes in providing advanced data and analytics technology and services tailored specifically for healthcare organizations. Their core offering, the Ignite Spark™ platform, is designed to empower mid-sized healthcare entities by streamlining data management and analytics, facilitating rapid decision-making, and enhancing operational efficiency. This platform encompasses a comprehensive ecosystem aimed at delivering actionable insights that drive clinical, operational, and financial improvements. Health Catalyst's clientele includes a diverse range of healthcare organizations, such as hospitals, healthcare systems, and other providers across North America, Europe, and selected regions in Asia.In the most recent year of 2022, Health Catalyst reported a revenue of USD 276.24 mn, with an EBITDA of USD -90.21 mn, primarily generated through a subscription-based model involving the deployment of its Ignite Spark™ platform and related analytical services.Following its IPO in July 2019, where Health Catalyst raised USD 182.00 mn, the company plans to utilize this funding to expand its healthcare technology and services. They are focusing on developing new product offerings and exploring geographic expansion into additional markets. Specific details about upcoming product releases and targeted regions for growth will be outlined in future communications.

## Funding rounds

- Series F, Feb 6, 2019, $12M — OrbiMed Advisors, Hong Shan, Norwest Venture Partners, Kaiser Permanente Ventures, Sands Capital Alternatives, UPMC Enterprises
- Series E, Feb 9, 2016, $70M — Hong Shan, EPIC Ventures, Norwest Venture Partners, Tenaya Capital, CHV Capital, Kaiser Permanente Ventures, Mass General Brigham Ventures, Leavitt Equity Partners, Sands Capital Alternatives, Transformation Capital, MultiCare, OSF HealthCare, UPMC Enterprises
- Series D, Mar 17, 2015, $70M — Hong Shan, EPIC Ventures, Norwest Venture Partners, Sorenson Capital, Tenaya Capital, CHV Capital, Kaiser Permanente Ventures, Mass General Brigham Ventures, Leavitt Equity Partners, Sands Capital Alternatives
- Series C, Dec 30, 2014, $13M — Hong Shan, Norwest Venture Partners, Sorenson Capital, CHV Capital, Kaiser Permanente Ventures
- Series C, Jan 28, 2014, $41M — Hong Shan, Norwest Venture Partners, Sorenson Capital, CHV Capital, Kaiser Permanente Ventures, Mass General Brigham Ventures
- Series B, Feb 28, 2013, $6.2M — CHV Capital, Kaiser Permanente Ventures
- Series B, Dec 21, 2012, $33M — Hong Shan, Norwest Venture Partners, Sorenson Capital
- Series A, Sep 22, 2011, $14M — Hong Shan

## Investors

- Hong Shan — Series A, Series B, Series C, Series D, Series E, Series F
- Norwest Venture Partners (https://capitalatlas.ai/funds/norwest-venture-partners) — Series B, Series C, Series D, Series E, Series F
- Sorenson Capital (https://capitalatlas.ai/funds/sorenson-capital) — Series B, Series C, Series D
- CHV Capital (https://capitalatlas.ai/funds/chv-capital) — Series B, Series C, Series D, Series E
- Kaiser Permanente Ventures (https://capitalatlas.ai/funds/kaiser-permanente-ventures) — Series B, Series C, Series D, Series E, Series F
- Mass General Brigham Ventures (https://capitalatlas.ai/funds/mass-general-brigham-ventures) — Series C, Series D, Series E
- EPIC Ventures (https://capitalatlas.ai/funds/epic-ventures) — Series D, Series E
- Tenaya Capital (https://capitalatlas.ai/funds/tenaya-capital) — Series D, Series E
- Leavitt Equity Partners (https://capitalatlas.ai/funds/leavitt-equity-partners) — Series D, Series E
- Sands Capital Alternatives (https://capitalatlas.ai/funds/sands-capital-alternatives) — Series D, Series E, Series F
- Transformation Capital (https://capitalatlas.ai/funds/transformation-capital) — Series E
- MultiCare — Series E
- OSF HealthCare — Series E
- UPMC Enterprises (https://capitalatlas.ai/funds/upmc-enterprises) — Series E, Series F
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series F